Pre-BladParadigm - the effect of diagnostic transurethral bladder tumor resection (TURBT) on the level of circulating tumor cells (CTCs) in the blood of patients suspected of muscle invasive bladder cancer

Pre-BladParadigm - the effect of diagnostic transurethral bladder tumor resection (TURBT) on the level of circulating tumor cells (CTCs) in the blood of patients suspected of muscle invasive bladder cancer - Pre-BladParadigm

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON50772

Enrollment

Registered

2021-06-17

Start date

2021-07-15

Completion date

Unknown

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients suspected of muscle invasive bladder cancer, planned for transurethral resection for local staging

Exclusion criteria

Exclusion criteria: Not capable of giving informed consent

Design outcomes

Primary

Measure	Time frame
Number of CTCs in 7.5 ml of blood taken from a peripheral vein before vs. after TURBT. In the second blood tube, CTCs will be isolated to check for metastatic potential by means of RNA expression.	—

Secondary

Measure	Time frame
None	—

Countries

Netherlands

Outcome results